JAMA review ignores chronic manifestations of Lyme disease

A review published in the Journal of the American Medical Association (JAMA) examines the efficacy of treatment for Lyme disease, anaplasmosis and babesiosis. [1] After a search yielded more than 4,000 articles, the authors reviewed 361 studies and concluded that a 7- to 14-day course of antibiotics is sufficient in treating early neurologic Lyme disease, as well as certain cases of babesiosis. [1] Unfortunately, the reviewers based their findings on a select group of articles, excluding findings demonstrating chronic manifestations of the disease.